Not cancer · Austria
Fatty liver disease (MASLD/MASH)
How is it diagnosed today? It is usually found after blood tests or scans done for another reason show signs of problems with your liver. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.6 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Weight loss, healthy diet and exercise. NHS
2 medicines are approved for this disease in Austria:
- Resmetirom (Rezdiffra) – approved in 2025
- Semaglutide (Kayshild, Wegovy Multi FixDose) – approved in 2026
An EU approval is valid in Austria. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Being tested in people
6 open trials in Austria, 271 worldwide. See the trials
- ALN-CIDEB (Phase 3)
- DR10624 Injection (Phase 3)
- Efimosfermin alfa (Phase 3)
- Efruxifermin (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 3 were in animals and 0 in the lab. See them
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Cannabis and cannabinoids (CBD, THC) (only single reports in people)
- Amygdalin (laetrile, "vitamin B17") (animal studies only)
- Mistletoe extract (animal studies only)
- Ivermectin (lab studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
6 open trials in Austria, and 3 opening soon or by invitation
Tests survodutide in adults with liver scarring from fatty liver disease
NCT06632457 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Linz – Ordensklinikum Linz GmbH
- Vienna – Klinik Hietzing
- and 1 more site
Age 18 and over
Contact the trial teamTests personalized diet feedback for fatty liver disease
NCT07914829 · ClinicalTrials.gov
- Vienna – Medical University of Vienna
Ages 18 to 80
Contact the trial teamTests survodutide in adults with liver disease and moderate or advanced liver fibrosis
NCT06632444 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Linz – Ordensklinikum Linz GmbH
- Vienna – Klinik Hietzing
- and 3 more sites
Age 18 and over
Contact the trial teamTests pegozafermin against placebo in liver scarring from fatty liver disease
NCT06318169 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Wels – Klinikum Wels-Grieskirchen GmbH
Ages 18 to 80
Contact the trial teamTests efimosfermin against placebo in adults with cirrhosis from MASH
2026-525755-82-00 · EU Clinical Trials Register
- Graz – Medical University of Graz
- Vienna – Klinik Hietzing
- Vienna – Medical University of Vienna
Age 18 and over
Contact the trial teamTests efimosfermin against placebo in adults with cirrhosis caused by MASH
2026-525757-37-00 · EU Clinical Trials Register
- Graz – Medical University of Graz
- Vienna – Medical University of Vienna
Age 18 and over
Contact the trial teamTests retatrutide and tirzepatide in adults with fatty liver disease at high risk
NCT07165028 · ClinicalTrials.gov
- Graz – Medizinische Universität Graz
- Salzburg – Uniklinikum Salzburg
- Vienna – Medizinische Universität Wien
- and 2 more sites
Age 18 and over
Contact the trial teamTests efimosfermin alfa injection in adults with fatty liver scarring
NCT07221188 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Vienna – Klinik Hietzing
- and 1 more site
Ages 18 to 75
Contact the trial teamCold Exposure to Test Fat Burning and Liver Fat in Fatty Liver Disease
NCT03811236 · ClinicalTrials.gov
- Vienna – Medical University of Vienna
Ages 18 to 50
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Available abroad (353 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Tests efruxifermin in adults with fatty liver disease and scarring
2023-505141-48-00 · EU Clinical Trials Register
Countries: Germany, Spain, France and 2 more
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
- Homburg, Germany – Universitaet Des Saarlandes
- Leipzig, Germany – Eugastro GmbH
Age 18 and over
Contact the trial teamTests efruxifermin in adults with cirrhosis caused by fatty liver disease
NCT06528314 · ClinicalTrials.gov
Countries: Belgium, Switzerland, Germany and 19 more
- Brussels, Belgium – hospital not given
- Edegem, Belgium – hospital not given
- Bern, Switzerland – hospital not given
Ages 18 to 80
Contact the trial teamSurvodutide and heart structure and function in people with obesity and fatty liver disease
NCT07850063 · ClinicalTrials.gov
Countries: Germany, Spain, United Kingdom and 2 more
- Bad Homburg, Germany – Zentrum für Klinische Studien Bad Homburg
- Erlangen, Germany – Universitätsklinikum Erlangen
- Freiburg im Breisgau, Germany – Universitätsklinikum Freiburg
Age 18 and over
Contact the trial teamImmune signs of fatty liver disease in people with type 1 diabetes
NCT07927647 · ClinicalTrials.gov
Countries: France
- Paris, France – Hospital, AP-HP, 2 rue Ambroise Paré, Paris, France (coordinating center) - Department of Diabetology, Bichat Hospital, AP-HP, 46 Rue Henri Huchard, Paris, France
Age 18 and over
Contact the trial teamTesting ALN-CIDEB for fatty liver disease with liver scarring in adults
NCT07631637 · ClinicalTrials.gov
Countries: Spain, United Kingdom, Italy and 2 more
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Madrid, Spain – Hospital General Universitario Gregorio Marañón
- Pontevedra, Spain – Complexo Hospitalario Universitario de Pontevedra
Ages 18 to 75
Contact the trial teamHow long adults with psoriasis and fatty liver disease stay on secukinumab
NCT07683065 · ClinicalTrials.gov
Countries: Spain
- Badalona, Spain – hospital not given
- Barcelona, Spain – hospital not given
- Madrid, Spain – hospital not given
Ages 18 to 100
Contact the trial teamTests efruxifermin in adults with liver scarring from fatty liver disease
NCT06215716 · ClinicalTrials.gov
Countries: Switzerland, Germany, Spain and 15 more
- Bern, Switzerland – hospital not given
- Olten, Switzerland – hospital not given
- Sankt Gallen, Switzerland – hospital not given
Ages 18 to 80
Contact the trial teamExercise Program for Fatty Liver Disease in Middle-Aged and Older Adults
NCT07467512 · ClinicalTrials.gov
Countries: Spain
- Madrid, Spain – Hospital General Universitario Gregorio Marañón
Age 40 and over
Contact the trial teamTests pegozafermin in adults with liver scarring from fatty liver disease
NCT06419374 · ClinicalTrials.gov
Countries: Belgium, Bulgaria, Germany and 22 more
- Anderlecht, Belgium – Hopital Erasme
- Edegem, Belgium – Antwerp University Hospital
- Genk, Belgium – Ziekenhuis Oost-Limburg
Ages 18 to 75
Contact the trial teamTests efruxifermin in adults with scarred liver from fatty liver disease
2024-512895-36-00 · EU Clinical Trials Register
Countries: Belgium, Germany, Denmark and 6 more
- Anderlecht, Belgium – Hopital Erasme
- Edegem, Belgium – Universitair Ziekenhuis Antwerpen
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
Age 18 and over
Contact the trial teamCollecting liver samples to build models for liver cancer and liver disease research
NCT04690972 · ClinicalTrials.gov
Countries: France
- Strasbourg, France – PU-PH, Directeur de l'UMR_S1110 Unité Inserm d'affiliation : UMR_S1110
Age 18 and over
Contact the trial teamEndohepatology Assessment in Adults at High Risk of Fatty Liver Disease
NCT07877272 · ClinicalTrials.gov
Countries: Germany
- Münster, Germany – University hospital Muenster
Age 18 and over
Contact the trial teamFollows liver fat and scarring in adults with type 2 diabetes over time
NCT07312136 · ClinicalTrials.gov
Countries: Sweden
- Linköping, Sweden – Department of Gastroenterology and Hepatology, Linköping University Hospital
Age 18 and over
Contact the trial teamBlood tests and phone programs for heart, kidney and diabetes risk
NCT07820800 · ClinicalTrials.gov
Countries: Finland
- Savonlinna, Finland – Wellbeing Services County of South Savo (Eloisa) (provide social and healthcare services and emergency services in the Enonkoski, Hirvensalmi, Juva, Kangasniemi, Mikkeli, Mäntyharju, Pieksämäki, Puumala, Rantasalmi, Savonlinna ja Sulkava)
Ages 45 to 55
Contact the trial teamDigital app support for people with fatty liver disease
NCT06879236 · ClinicalTrials.gov
Countries: Italy
- Rome, Italy – Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Medicina Trapianti Fegato and UOC CEMAD
Age 18 and over
Contact the trial teamTests tailored lifestyle counselling for fatty liver disease in adults
NCT05816915 · ClinicalTrials.gov
Countries: Czechia
- Prague, Czechia – General University Hospital
Age 18 and over
Contact the trial teamFollowing people at risk of fatty liver disease to detect liver scarring
NCT07775638 · ClinicalTrials.gov
Countries: Norway
- Stavanger, Norway – Stavanger University Hospital
Ages 40 to 70
Contact the trial teamSemaglutide and Alcohol Use in People With Obesity and Fatty Liver
NCT06546384 · ClinicalTrials.gov
Countries: Switzerland
- Bern, Switzerland – University Hospital Bern
Ages 18 to 80
Contact the trial teamScreening tool for fatty liver disease using body impedance measurement
NCT04873258 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge
Ages 18 to 80
Contact the trial teamStudying heart function in people with alcohol-related cirrhosis receiving a liver shunt
NCT06814990 · ClinicalTrials.gov
Countries: Germany
- Jena, Germany – Jena University Hospital
Ages 18 to 99
Contact the trial teamCompares Weight-Loss Surgery and Medicines for Fatty Liver Scarring
NCT06374875 · ClinicalTrials.gov
Countries: Switzerland, Spain, Finland and 10 more
- Basel, Switzerland – Clarunis Universitäres
- Geneva, Switzerland – Hôpitaux universitaires de Genève
- Barcelona, Spain – Hospital Clinic Barcelona
Ages 18 to 75
Contact the trial teamTesting how fructose sugar affects liver inflammation in people with fatty liver disease
NCT07013916 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London
- London, United Kingdom – Royal London Hospital
Ages 45 to 65
Contact the trial teamPectin Supplement Tested for Inflammation and Gut Bacteria in Fatty Liver Disease
NCT07093346 · ClinicalTrials.gov
Countries: United Kingdom
- Nottingham, United Kingdom – Nottingham Clinical Research Facility at Nottingham University Hospitals NHS Trust
- Nottingham, United Kingdom – University of Nottingham
- Nottingham, United Kingdom – Sir Peter Mansfield Imaging Centre, University of Nottingham
Age 18 and over
Contact the trial teamFollowing people with fatty liver disease to build a shared patient cohort
NCT07051863 · ClinicalTrials.gov
Countries: Switzerland
- Lugano, Switzerland – Fondazione Epatocentro Ticino
Age 18 and over
Contact the trial teamStudying fats and tiny blood particles in autoimmune hepatitis compared with fatty liver disease
NCT07644936 · ClinicalTrials.gov
Countries: Italy
- Castellana Grotte, Italy – IRCCS "S. de Bellis" - Nutritional Biochemistry Lab
Age 18 and over
Contact the trial teamExercise at different intensities for metabolic dysfunction-associated steatotic liver disease
NCT06506513 · ClinicalTrials.gov
Countries: Belgium
- Brussels, Belgium – Cliniques universitaires Saint-Luc
- Louvain-la-Neuve, Belgium – Centre d'investigation clinique en nutrition
Ages 18 to 70
Contact the trial teamChecks the liver for fat and scarring in people with Cushing syndrome
NCT05881005 · ClinicalTrials.gov
Countries: France
- Angers, France – University Hospital Angers
- Bordeaux, France – University Hospital Bordeaux
- Brest, France – University Hospital Brest
Age 18 and over
Contact the trial teamTests BI 3804379 Doses in Healthy People and Liver Fibrosis Patients
NCT06575400 · ClinicalTrials.gov
Countries: Belgium
- Edegem, Belgium – SGS Life Science Services - Clinical Research
Ages 18 to 65
Contact the trial teamButyrate or intensive lifestyle changes for fatty liver in adults with type 1 diabetes
NCT07684248 · ClinicalTrials.gov
Countries: Spain
- Málaga, Spain – Hospital Regional Universitario de Málaga, FIMABIS
Ages 18 to 75
Contact the trial teamBlood tests to find liver scarring in fatty or alcohol-related liver disease
NCT05699018 · ClinicalTrials.gov
Countries: France
- Angers, France – ANGERS
- Angers, France – CHU Angers
- Baugé-en-Anjou, France – BAUGE
Ages 40 to 80
Contact the trial teamEating Only During Daytime Hours for Fatty Liver Disease in People With Obesity
NCT07378072 · ClinicalTrials.gov
Countries: France
- Angers, France – CHU Angers
- Bordeaux, France – CHU Bordeaux
- Dijon, France – Chu Dijon Bourgogne
Ages 18 to 65
Contact the trial teamDiet and exercise program for people with fatty liver disease linked to metabolism
NCT07652151 · ClinicalTrials.gov
Countries: Spain, Italy, Turkey (Türkiye)
- Seville, Spain – Hospital Universitario Virgen del Rocío de Sevilla
- Roma, Italy – Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Internal Medicine and Liver Transplantation Unit
- Ankara, Turkey (Türkiye) – Hacettepe University
Age 18 and over
Contact the trial teamStudies how gut bacteria produce certain metabolites in people with fatty liver disease
NCT07313007 · ClinicalTrials.gov
Countries: France
- Pierre-Bénite, France – Centre Hospitalier Lyon Sud Service Endocrinologie, Diabète et nutrition
Ages 18 to 80
Contact the trial teamAutomatic blood-test screening for advanced liver scarring in people with fatty liver disease
NCT07658755 · ClinicalTrials.gov
Countries: Spain
- Madrid, Spain – Hospital General Universitario Gregorio Marañón
Ages 50 to 75
Contact the trial teamFrailty in men and women with fatty liver disease linked to metabolic problems
NCT07652892 · ClinicalTrials.gov
Countries: Spain
- Barcelona, Spain – Hospital de la Santa Creu i Sant Pau
Ages 20 to 80
Contact the trial teamTests MRI scans to find non-invasive markers of fatty liver disease
NCT06626074 · ClinicalTrials.gov
Countries: France
- Angers, France – University Hospital Angers
- Rennes, France – CHU de Rennes
Age 18 and over
Contact the trial teamChecks liver fat in adults born with low birth weight
NCT05890365 · ClinicalTrials.gov
Countries: Denmark
- Herlev, Denmark – Steno Diabetes Center Copenhagen
Ages 34 to 49
Contact the trial teamMeal Timing in People With Fatty Liver Disease and in New Mothers
NCT07630636 · ClinicalTrials.gov
Countries: United Kingdom
- Cambridge, United Kingdom – Cambridge Clinical Research Centre
Ages 18 to 80
Contact the trial teamStudies immune and metabolic changes in fatty liver disease
NCT04141592 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Homerton University Hospital Foundation Trust
Age 18 and over
Contact the trial teamBlood Tests to Detect Scarring in Fatty Liver Disease
NCT06819917 · ClinicalTrials.gov
Countries: Germany, Denmark
- Mainz, Germany – Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Copenhagen, Denmark – Hvidovre Hospital
Ages 18 to 75
Contact the trial team
Showing 40 of 353. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- Integrated chemical profiling and lipidomics reveal that Mailuoning oral liquid alleviates diet-induced MASLD via PPARα-mediated lipid homeostasis and COX-2 inhibition, with identification of potential active constituents.Front Pharmacol · 2026-10-29
- In peopleAssociation between systemic immune-inflammation index and skeletal muscle mass in patients with nonalcoholic fatty liver disease: A cross-sectional study.Medicine (Baltimore) · 2026-11-13
- In animalsTubastatin A Mitigates Lipotoxicity, Inflammation and Fibrosis Through Downregulation of HDAC6 and Modulation of AMPK-FGF21 Axis in Metabolic Dysfunction-Associated Steatohepatitis.Inflammation · 2026-08-11
- In peopleMetabolic Dysfunction-Associated Steatotic Liver Disease, With and Without Increased Alcohol Intake, and Incident Atrial Fibrillation in Older Korean Adults: A Competing-Risk Cohort Study.Geriatr Gerontol Int · 2026-11-01
- Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic burden with urinary tubular biomarker abnormalities: a cross-sectional health examination study.Front Med (Lausanne) · 2026-10-29
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Hepatitis Hilfe Österreich – Plattform Gesunde Leber
Nationwide non-profit patient organisation for all liver diseases, founded in 1999 by patients: counselling, information leaflets and support for patients and relatives.
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (4)
- European Liver Patients' Association (ELPA)
European umbrella of national liver patient groups: liver disease information, HCC patient guide (with ESMO), clinical trial finder and liver cancer advocacy; points patients to member groups.
- Global Liver Institute (GLI)
Global liver health advocacy body with a Liver Cancers Council, patient/caregiver education events and advocate training; not a direct support service.
Phone: +1 800 845 5910
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.